Astonea Labs IPO

Incorporated in 2017, Astonea Labs Ltd. is engaged in contract manufacturing of pharmaceutical and cosmetic products for companies both within India and internationally. The company manufactures and markets a variety of pharmaceutical and cosmetic products, including antibiotics, anti-cold medicines, antihistamines, and treatments for diabetes, heart, gynecological issues, infections, and more. The company offers skin, tooth, and hair care products in forms like gels, creams, and serums, and also trades packaging and raw materials for pharmaceutical and cosmetic industries, meeting industry standards. The company engages in contract manufacturing of pharmaceutical and cosmetic products, markets its own brands "Glow Up" and "Regero," plans to launch "Avicel," and exports to countries like Iraq and Yemen. Produts and Offerings: Products under our own brands: The company markets “Glow Up” skincare and “Regero” pharma products, offering diverse affordable solutions. Products under contract manufacturing: The company provides pharmaceutical and cosmetic products under contract manufacturing, primarily for domestic and export markets. As of August 16, 2024, the company had 217 employees on payroll. Competitive Strengths: Experienced management and dedicated employee base Scalable business model Wide and diverse range of product offerings Quality Service

The Company Astonea Labs IPO proposes to utilise the Net Proceeds from the Issue towards the following objects: S.No. Objects of the Issue Expected Amount (in Millions) 1 Funding of expenses proposed to be incurred towards registration in Bolivia, South America 12.90 2 Purchase and installation of plant and machineries for ointment production for the purpose of export in accordance with the international standards and protocols, on the 2nd floor of the Existing Premises 52.34 3 Advertising, marketing and brand building 49.52 4 Investment in procuring hardware and software 6.84 5 Funding of working capital requirements 197.50 6 General corporate purposes

All matter published here is purely for educational and information purposes only and under no circumstances should be used for making investment decisions. We are not a SEBI Registered analyst. Readers must consult a qualified financial advisor prior to making any actual investment decisions, based on Information published on this application. No financial information whatsoever published anywhere, within this application, should be considered as advice to buy or sell securities or invest in IPOs, or as a guide to doing so in any way whatsoever Please read all Tearms and conditions , and agree to use the App